PortfoliosLab logoPortfoliosLab logo
UTI vs. MEDP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UTI vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Universal Technical Institute, Inc. (UTI) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UTI achieves a 70.42% return, which is significantly higher than MEDP's -19.73% return.


UTI

1D
6.89%
1M
20.12%
YTD
70.42%
6M
78.05%
1Y
25.79%
3Y*
89.54%
5Y*
49.26%
10Y*
30.83%

MEDP

1D
1.17%
1M
8.10%
YTD
-19.73%
6M
-21.80%
1Y
47.29%
3Y*
28.58%
5Y*
21.65%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

UTI vs. MEDP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTI
Universal Technical Institute, Inc.
70.42%1.63%105.35%86.31%-14.07%21.05%-16.21%111.23%52.08%-17.53%
MEDP
Medpace Holdings, Inc.
-19.73%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%

Correlation

The correlation between UTI and MEDP is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Aug 12, 2016

0.16

The correlation between UTI and MEDP shifts across timeframes, from 0.01 (1 year) to 0.19 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

UTI:

$2.48B

MEDP:

$13.06B

EPS

UTI:

$0.77

MEDP:

$15.63

PE Ratio

UTI:

58.13

MEDP:

28.84

PEG Ratio

UTI:

0.38

MEDP:

0.87

PS Ratio

UTI:

2.85

MEDP:

4.96

PB Ratio

UTI:

7.30

MEDP:

21.82

Total Revenue (TTM)

UTI:

$868.99M

MEDP:

$2.68B

Gross Profit (TTM)

UTI:

$208.88M

MEDP:

$778.59M

EBITDA (TTM)

UTI:

$76.70M

MEDP:

$572.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTI vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTI
UTI Risk / Return Rank: 5555
Overall Rank
UTI Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
UTI Sortino Ratio Rank: 5353
Sortino Ratio Rank
UTI Omega Ratio Rank: 5555
Omega Ratio Rank
UTI Calmar Ratio Rank: 5656
Calmar Ratio Rank
UTI Martin Ratio Rank: 5656
Martin Ratio Rank

MEDP
MEDP Risk / Return Rank: 6868
Overall Rank
MEDP Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 6969
Sortino Ratio Rank
MEDP Omega Ratio Rank: 7878
Omega Ratio Rank
MEDP Calmar Ratio Rank: 6565
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTI vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Universal Technical Institute, Inc. (UTI) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UTIMEDPDifference

Sharpe ratio

Return per unit of total volatility

0.47

0.69

-0.22

Sortino ratio

Return per unit of downside risk

0.94

1.70

-0.75

Omega ratio

Gain probability vs. loss probability

1.14

1.29

-0.15

Calmar ratio

Return relative to maximum drawdown

0.67

1.30

-0.63

Martin ratio

Return relative to average drawdown

1.49

2.98

-1.49

UTI vs. MEDP - Sharpe Ratio Comparison

The current UTI Sharpe Ratio is 0.47, which is lower than the MEDP Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of UTI and MEDP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UTIMEDPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.47

0.69

-0.22

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.03

0.42

+0.61

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.58

Sharpe Ratio (All Time)

Calculated using the full available price history

0.07

0.66

-0.59

Drawdowns

UTI vs. MEDP - Drawdown Comparison

The maximum UTI drawdown since its inception was -96.06%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for UTI and MEDP.


Loading charts...

Drawdown Indicators


UTIMEDPDifference

Max Drawdown

Largest peak-to-trough decline

-96.06%

-42.87%

-53.19%

Max Drawdown (1Y)

Largest decline over 1 year

-38.90%

-36.61%

-2.29%

Max Drawdown (3Y)

Largest decline over 3 years

-39.36%

-39.38%

+0.02%

Max Drawdown (5Y)

Largest decline over 5 years

-51.19%

-42.87%

-8.32%

Max Drawdown (10Y)

Largest decline over 10 years

-61.88%

Current Drawdown

Current decline from peak

0.00%

-27.36%

+27.36%

Average Drawdown

Average peak-to-trough decline

-65.69%

-12.89%

-52.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.31%

15.92%

+1.39%

Volatility

UTI vs. MEDP - Volatility Comparison

Universal Technical Institute, Inc. (UTI) has a higher volatility of 21.61% compared to Medpace Holdings, Inc. (MEDP) at 7.02%. This indicates that UTI's price experiences larger fluctuations and is considered to be riskier than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UTIMEDPDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.61%

7.02%

+14.59%

Volatility (6M)

Calculated over the trailing 6-month period

38.26%

38.13%

+0.13%

Volatility (1Y)

Calculated over the trailing 1-year period

55.28%

69.32%

-14.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.03%

51.61%

-3.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

53.47%

49.82%

+3.65%

Dividends

UTI vs. MEDP - Dividend Comparison

Neither UTI nor MEDP has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
MEDP
Medpace Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UTI
Universal Technical Institute, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.69%5.15%

Financials

UTI vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Universal Technical Institute, Inc. and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00M20222023202420252026
221.40M
706.60M
(UTI) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

UTI vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between Universal Technical Institute, Inc. and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-40.0%-20.0%0.0%20.0%40.0%60.0%20222023202420252026
-49.6%
27.8%
Portfolio components
UTI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Universal Technical Institute, Inc. reported a gross profit of -109.80M and revenue of 221.40M. Therefore, the gross margin over that period was -49.6%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

UTI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Universal Technical Institute, Inc. reported an operating income of 339.00K and revenue of 221.40M, resulting in an operating margin of 0.2%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

UTI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Universal Technical Institute, Inc. reported a net income of 433.00K and revenue of 221.40M, resulting in a net margin of 0.2%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.


Frequently Asked Questions


UTI and MEDP have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

UTI has higher volatility (21.61%) compared to MEDP (7.02%). In terms of maximum drawdown, UTI dropped -96.06% vs MEDP's -42.87%.

MEDP currently has the higher Sharpe Ratio (0.69 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UTI and MEDP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer